In this 30-minute Q&A with journalist Josh Long, two former officials with the Food and Drug Administration who established policies for dietary supplement products will examine the agency’s proposed reorganization of the Office of Dietary Supplement Programs, its potential impact on industry and concerns raised by U.S. lawmakers and others.
They also will discuss FDA’s enforcement practices amid a proliferation of counterfeit products on the market, as well as growing concerns over FDA’s interpretation of the “drug preclusion” clause.
Click here to download Speaker Presentation
They also will discuss FDA’s enforcement practices amid a proliferation of counterfeit products on the market, as well as growing concerns over FDA’s interpretation of the “drug preclusion” clause.
Click here to download Speaker Presentation
Date & Time
Thursday October 26th, 2023 11:15am PDT
End Date & Time
Thursday October 26th, 2023 11:45am PDT
Location
Booth #5670
| MODERATOR |
 Josh LongAssociate Director, Editorial, Natural Products Insider Josh Long is associate director of editorial with Natural Products Insider. He has been a journalist since 1997 and has been covering the natural products industry for over a decade. Josh also holds a J.D. from the University of Wyoming College of Law, and he was admitted to practice law in Colorado in 2008. |
| SPEAKERS |
 Robert DurkinPartner, Arnall, Golden, Gregory LLP |
| Daniel Fabricant CEO / President, Natural Products Association Daniel Fabricant, Ph.D., is the president and CEO of the Natural Products Association in Washington, D.C., which has a history as the defender of the industry going back generations and represents over 700 members accounting for more than 10,000 retail, manufacturing, wholesale and distribution locations of natural products, including foods, dietary supplements and health/beauty aids. He is regarded as an expert on FDA, especially in the dietary supplement industry. During part of the Obama administration, he was the agency’s top official overseeing the Division (now Office) of Dietary Supplement Programs. While at the agency, Dan was instrumental in several key enforcement actions—including actions in response to an outbreak of non-hepatitis liver injuries tied to dietary supplements—to protect public health. Moreover, under Daniel’s leadership, NPA filed a lawsuit in recent years against FDA in U.S. District Court, which ultimately led to a favorable outcome for industry over an ingredient widely marketed in dietary supplements called NAC. Daniel is recognized as one of the top NPA lobbyists in D.C. |
Category SupplySide Stage